Also known as Delta Sleep-Inducing Peptide
Endogenous nonapeptide first isolated for its sleep-promoting properties.
DSIP is a nine-amino-acid neuropeptide first isolated from rabbit cerebral venous blood. Reported effects span sleep architecture, stress response, and circadian rhythm modulation.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nine-amino-acid neuropeptide, first isolated in the 1970s from the blood of rabbits during induced sleep. Its name reflects the early observation that it promoted slow-wave (delta) sleep.
Decades of research have linked DSIP to sleep architecture, stress-response regulation, and circadian rhythm, but its precise mechanism and receptor remain incompletely characterized. It is a research compound and is not FDA-approved.
Mechanism remains incompletely characterized; likely multimodal CNS modulation.
Behind every vial of DSIP is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how DSIP, specifically, is brought into being.
On paper, DSIP is C35H48N10O15 — about 848.8 daltons of precisely arranged atoms. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Assembling DSIP means roughly 9 coupling cycles on the synthesizer — one protected residue added at a time, which is also 9 chances for an incomplete coupling to seed a deletion impurity. It is a short sequence, which makes the build comparatively tractable — but short does not mean trivial, and purity is still won or lost downstream.
The crude mixture — DSIP plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one. It also contains oxidation-prone methionine or tryptophan residues, another family of impurities the chromatography has to resolve away.
A real batch of DSIP proves itself: identity confirmed by mass spectrometry against its ~848.8 Da, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of DSIP — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Producing DSIP to a genuine purity spec means solid-phase synthesis, preparative HPLC purification, and batch quality control — none of it cheap, and none of it something you can verify by eye.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Recent clinical trials and publications mentioning Delta Sleep-Inducing Peptide, pulled automatically from ClinicalTrials.gov and PubMed and refreshed daily. Listings are unfiltered search results, not curated endorsements.
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring neuropeptide first isolated for its sleep-promoting properties, studied in sleep and stress research.
Its mechanism is not fully characterized; it is thought to act through multiple central nervous system pathways rather than a single identified receptor.
Sleep architecture, stress physiology, and circadian rhythm modulation.
No — it is a research compound. This page is a research and educational reference.
Russian synthetic ACTH(4-10) analog studied for nootropic and neuroprotective effects.
ViewSynthetic heptapeptide analog of tuftsin investigated as an anxiolytic.
ViewA 9-amino-acid cyclic hormone of labor and bonding — historically the first peptide hormone ever chemically synthesized, and the most over-marketed "love hormone."
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.